title: Immunological tolerance and tumor rejection in embryo-aggregated chimeric mice - lessons for tumor immunity.
abstract: BACKGROUND
  Rejection of transplanted tumors by the immune system is a rare event in syngeneic hosts, and is considered to be dependent on the local interaction of defensive immune reactions and tumor tolerance mechanisms. Here, we have enlisted the aid of a unique set of embryo-aggregated lineage chimeric mice derived from C57/BL6 and FVB donors to study the interplay between local and systemic tumor immunity and tolerance in rejection of mouse B16 melanoma cells, syngeneic to the C57/BL6 donor strain.
  
  
  METHODS
  Two variants of embryo-aggregated chimeric mice with either variable or no contribution of C57-derived cells to their skin were generated by the fusion of different ratios of morula stage blastomers. Chimeric mice were analyzed for s.c. growth of B16 tumors in comparison to their respective donor strains as well as normal F1 hybrids, and the relative frequencies of cellular components of the immune system by FACS analysis of peripheral blood or lymph node cells.
  
  
  RESULTS
  B16 tumors grew significantly faster in mice with full chimerism in their skin as compared to syngeneic C57 or semi-syngeneic C57 x FVB F1 hosts. In contrast, s.c. tumor growth was either absent or significantly reduced in chimeric mice lacking C57-derived cells in their skin, but tolerant to C57 tissue in other organs. Comparison of the relative frequencies of various immune cells in the periphery via FACS-analysis did not reveal any significant differences between the two types of chimeric mice with respect to their donor strains.
  
  
  CONCLUSIONS
  Our data suggest a complex interplay between mechanisms of local peripheral tolerance and innate antitumor mechanisms possibly involving NK cell allorecognition as a basis for the differential growth or rejection of B16 tumors in these unique chimeric mice, which we suggest to constitute a valuable new model system for the study of immune-mediated tumor rejection.
authors.affiliation: The Oncology Research Institute, Greenville Hospital System University Medical Center, Greenville, SC 29605, USA. alex.y.wagner@gmail.com
authors.forename: Alexander Y
authors.initials: AY
authors.lastname: Wagner
authors.forename: Eric
authors.initials: E
authors.lastname: Holle
authors.forename: Lori
authors.initials: L
authors.lastname: Holle
authors.forename: Xianzhong
authors.initials: X
authors.lastname: Yu
authors.forename: Günter
authors.initials: G
authors.lastname: Schwamberger
mesh_terms: D000818:Animals; D002678:Chimera; D006084:Graft Rejection / Q000276:immunology*; D007108:Immune Tolerance; D007962:Leukocytes / Q000276:immunology; D008198:Lymph Nodes / Q000276:immunology; D008546:Melanoma, Experimental / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009028:Morula; D009368:Neoplasm Transplantation; D013601:T-Lymphocytes / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000378:metabolism; D023001:Transplantation Tolerance